Strategy's share sales from its at-the-market offering were just below 3% of the total cumulative trading volume.

DoubleDragon Corp., the property venture of tycoons Edgar “Injap” Sia and Tony Tan Caktiong, has moved a step closer toward ...

Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into ...

The Nasdaq Composite is an often-cited stock market index — along with the S&P 500 and the Dow Jones Industrial Average — ...

Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine ...

Follow along for live updates on stocks, bonds and markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq ...

Hotel101 Global—a unit of DoubleDragon, which is jointly owned by Philippine fast food giant Jollibee founder Tony Tan ...

The shipping pool operator and commercial manager, led and controlled by Pankaj Khanna, is aiming to combine with ...

We recently compiled a list of the 10 Best Blockchain Stocks to Buy According to Analysts. In this article, we are going to ...

As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the real estate services industry ...

The options have an exercise price of $7.90 per share, which is equal to the closing price of BioCryst common stock on the ...

DOUBLEDRAGON Corp.’s (DD) subsidiary, Hotel101 Global Pte. Ltd., is nearing its $2.3-billion (P130 billion) listing on the Nasdaq Stock Exchange in the United States after meeting all requirements.